Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.0075 | 0.8 |
mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.0076 | 0.8 |
mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |
mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.014 | 0.8 |
mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |
mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |
mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |
mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |
mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.017 | 0.8 |